NMDA antagonists in the treatment of catatonia: A review of case studies from the last 10 years-Reference-Cited by-同舟云学术

NMDA antagonists in the treatment of catatonia: A review of case studies from the last 10 years

Published:2018-03 Issue: Volume:51 Page:132-133
ISSN:0163-8343
Container-title:General Hospital Psychiatry
language:en
Short-container-title:General Hospital Psychiatry

Author:

Theibert Heather P.M.,Carroll Brendan T.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health

Reference4 articles.

1. Diagnostic and statistical manual of mental disorders;American Psychiatric Association,2013

2. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes;Carroll;J Neuropsychiatry Clin Neurosci,2007

3. NMDA antagonists in the treatment of catatonia: a review of case studies from the last 10years. Poster presented at: Ohio Osteopathic Symposium;Theibert,2017

4. Alternative treatment strategies for catatonia: a systematic review;Beach;Gen Hosp Psychiatry,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-methyl-d-aspartate (NMDA) receptor antagonists for treatment of catatonia in adults: Narrative review;General Hospital Psychiatry;2024-11

2. Pharmacologic Treatment of Malignant Catatonia Without Electroconvulsive Therapy: A Case Report;Cureus;2024-04-11

3. Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands (11C-NR2B-Me enantiomers) have high binding in cerebellum but not to σ1 receptors;EJNMMI Research;2023-04-05

4. Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology;Journal of Psychopharmacology;2023-04

5. Catatonia associated with epileptic seizures: A systematic review of case reports;Epilepsy Research;2022-10